1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. LILLY(ELI) & CO
Lilly(Eli) & Co
XNYS: LLY

Eli Lilly Live Stock Price Today, Share Analysis and Chart

Mid-range Performer
about

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumia...

Read More
990.37 13.12 (1.34%)
58.77% Gain from 52W Low
1.2M
XNYS Volume

XNYS 13 Mar, 2026 2:18 PM (EDT)

Watchlist

Portfolio

Alert
Capex
Eli Lilly to invest $3 bn in China to expand supply chain and produce obesity drug orforglipron See details
Durability score
Medium Financial Strength
44.4 / 100
Valuation Score
Mid Valuation
32.0 / 100
Momentum Score
Technically Neutral
49.1 / 100
Mid-range Performer These stocks have average quality, financial and technical momentum, indicating a mid range performer View Similar Embed DVM
Analyst Price Target
1,217
1Yr Price target upside is 23%
29 analysts

15

S

6

W

6

O

0

T

SWOT Analysis

Eli Lilly Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..